Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer: Page 3
Freenome raises $254M in funding to advance cancer test pipeline
By
LabPulse.com staff writers
Biotech firm Freenome has raised $254 million in new funding from new and existing investors to accelerate its pipeline of early detection cancer tests for its multiomics platform.
February 15, 2024
Gold-enhanced nanopore sensors detect ovarian cancer biomarker in urine
By
Nick Paul Taylor
Nanopore sensors that use gold nanoparticles to capture certain peptides could enable the detection of ovarian cancer biomarkers in urine samples, according to a paper published in ACS Sensors.
February 14, 2024
High hopes for accurate blood test detecting malignant brain tumors
By
Matt Limb
A simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.
February 9, 2024
U.K. trial for mRNA-based cancer therapy begins
By
Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
NHS launches Jewish BRCA mutations testing program
By
LabPulse.com staff writers
The U.K. National Health Service (NHS) is launching a national genetic testing program aimed at people in England with Jewish ancestry who may be carriers of mutations in BRCA1 and BRCA2 genes that increase their risk of certain cancers.
February 5, 2024
Hologic receives FDA clearance for digital cytology scanner platform in U.S.
By
Liz Carey
Acknowledging human papillomavirus (HPV) as a causative agent for cervical cancer, the new system is designed to complement molecular testing for HPV with cotesting for cervical cancer.
February 2, 2024
DermTech to lay off 30 employees, take further restructuring measures
By
LabPulse.com staff writers
DermTech will lay off 30 employees and take additional restructuring measures to cut operating expenses, streamline operations, and focus its resources on revenue growth.
February 1, 2024
FDA orders new info warnings on CAR-T therapies
By
LabPulse.com staff writers
Following its review of reports of T-cell malignancies associated with the administration of six CAR-T immunotherapies, the FDA has instructed the manufacturers to include warnings in the prescribing info for the therapeutics.
January 30, 2024
Study uncovers role of genetic variants in blood cancer development
By
Matt Limb
Scientists have used large scale data analysis to investigate why only some people with a common mutation go on to develop rare blood cancer.
January 23, 2024
Genetic-informed model improves prediction of blood cancer prognosis
By
Nick Paul Taylor
Researchers have used genetic, treatment, and clinical data to improve prediction of the prognosis of patients with multiple myeloma.
January 18, 2024
Weill Cornell study may support new prognostic test for prostate tumor spread
By
LabPulse.com staff writers
Scientists working in the department of pathology and laboratory medicine at Weill Cornell Medicine have found that certain noncancerous cells may be useful for assessing prostate tumors and their potential to spread.
January 16, 2024
Geneoscopy requests review of Exact Sciences patent, dismissal of lawsuit
By
LabPulse.com staff writers
In the latest development in the patent infringement dispute between the two companies, Geneoscopy has petitioned the U.S. Patent and Trademark Office for inter partes review, challenging the patent in contention held by Exact Sciences.
January 12, 2024
Previous Page
Page 3 of 96
Next Page